Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (52)

2023

  1. Prevalence and Risk Factors for Airflow Limitation in Patients With Acute Coronary Syndrome

    Archivos de Bronconeumologia, Vol. 59, Núm. 6, pp. 397-400

2022

  1. At-admission HbA1c levels in hospitalized COVID-19 participants with and without known diabetes

    Clinica Chimica Acta, Vol. 532, pp. 188-192

  2. The oxyhaemoglobin dissociation curve is generally left-shifted in COVID-19 patients at admission to hospital, and this is associated with lower mortality

    British Journal of Haematology, Vol. 199, Núm. 3, pp. 332-338

2021

  1. Blood eosinophil count as predictor of asthma exacerbation. A meta-analysis

    Pediatric Allergy and Immunology, Vol. 32, Núm. 3, pp. 465-478

2019

  1. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats

    Biochemical Pharmacology, Vol. 170

  2. Prediabetes defined by HbA1c and by fasting glucose: differences in risk factors and prevalence

    Acta Diabetologica, Vol. 56, Núm. 9, pp. 1023-1030

2018

  1. Continuous glucose monitoring is more sensitive than HbA1c and fasting glucose in detecting dysglycaemia in a Spanish population without diabetes

    Diabetes Research and Clinical Practice, Vol. 142, pp. 100-109

2017

  1. Corrected Fructosamine improves both correlation with HbA1C and diagnostic performance

    Clinical Biochemistry, Vol. 50, Núm. 3, pp. 110-115

2016

  1. Impact of mean cell hemoglobin on Hb A1c-defined glycemia status

    Clinical Chemistry, Vol. 62, Núm. 12, pp. 1570-1578

2015

  1. Influence of the glycation gap on the diagnosis of type 2 diabetes

    Acta Diabetologica, Vol. 52, Núm. 3, pp. 453-459

2012

  1. Estimation of the glycation gap in diabetic patients with stable glycemic control

    Diabetes Care, Vol. 35, Núm. 12, pp. 2447-2450

  2. Intrapersonal HbA1c variability and the risk of progression of nephropathy in patients with Type2 diabetes

    Diabetic Medicine, Vol. 29, Núm. 12, pp. 1562-1566

2011

  1. Progression of nephropathy in type 2 diabetes: The glycation gap is a significant predictor after adjustment for glycohemoglobin (Hb A1c)

    Clinical Chemistry, Vol. 57, Núm. 2, pp. 264-271

  2. The influence of valproic acid and carbamazepine treatment on serum biotin and zinc levels and on biotinidase activity

    Journal of Child Neurology

2010

  1. Autoantibodies to glial fibrillary acid protein and S100β in diabetic patients

    Diabetic Medicine, Vol. 27, Núm. 2, pp. 246-248

2009

  1. Translating the A1C assay into estimated average glucose values

    Diabetes Care

2008

  1. Therapeutic criteria in communicating childhood hydrocephalus

    Journal of Neurosurgical Sciences, Vol. 52, Núm. 1, pp. 17-21

2007

  1. Evolution of Subclinical Hypothyroidism in Children Treated With Antiepileptic Drugs

    Pediatric Neurology, Vol. 37, Núm. 6, pp. 426-430

  2. Tissue-polypeptide-specific antigen levels in diabetic patients with normal and pathological biochemical profiles

    Clinical Biochemistry, Vol. 40, Núm. 3-4, pp. 278-281

2006

  1. Treatment of Mitochondrial Encephalomyopathies With a Xanthine Oxidase Inhibitor

    Pediatric Neurology, Vol. 35, Núm. 5, pp. 318-322